Medical Value Internship

Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.

The Position

Medical Value Internhip(s) at Roche Diagnostics Nederland

Who we are

At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe. Our core business is the discovery, development and manufacturing of in vitro tests for the diagnosis of various diseases that include cancer, diabetes, Covid-19, Alzheimer’s Disease, and many others. In vitro diagnostic tests can detect disease, conditions and infections done on samples such as blood or tissue.

We are transforming healthcare with innovation and collaboration. Using an evidence-based approach, our insights-driven digital health solutions aim to support patient care. We have a rich heritage in healthcare innovation and care reinvention. We can leverage diagnostic data and turn them into insights. These insights in combination with our diagnostic innovations, allow informed (clinical) decision making and improve healthcare.

What we are looking for

Patients, science and people are at the heart of everything we do. With our innovations, collaboration and medical breakthroughs we envision a sustainable healthcare. We are therefore looking for young talents to bring us insights from the market and provide fresh perspectives. We have several internship opportunities, which are explained in more detail below.

We are looking for you if you:

• are a Master student in medical sciences, pharmaceutical sciences, biology, or comparable, with a specialisation in innovation, entrepreneurship or business

• or a (health) economics student with an interest in healthcare sustainability

• are looking for a full-time internship of 5-6 months, starting in February 2025

• are passionate to improve patient care and innovations that can contribute

• are curious, ask question, and engage proactively

• want to experience what it is like to work in an international healthcare organisation

What we can offer

As an intern you will work closely with the healthcare transformation and medical value teams. Your supervisor is an experienced healthcare professional, who will provide you guidance and mentorship, and connect you to the relevant stakeholders within the organisation as well as in the healthcare system. Additionally, you will receive a laptop, an internship fee, and a great experience.

Our challenge in Multiple Sclerosis

Neurofilaments are neuron-specific intracellular cytoskeletal proteins, Neurofilament light chain (NfL) is the most studied subunit. Using NfL as a biomarker in blood can provide clinically useful information about prognosis and therapeutic efficacy in multiple sclerosis (MS). This biomarker can potentially be used along MRI and clinical measures as decision-making tools for the management of patients with MS.

During this internship you will work on the implementation of Nfl as a decision-making tool for the management of patients with MS. You will look into what is needed for adoption, identify barriers, inventorize evidence that needs to be generated and will take a deep dive in the MS landscape. This includes a multi-stakeholder analysis based on interviews, which provides us with insights into the perspectives of various important stakeholders. You will give us business recommendations on how to go forward in which the competitive landscape will also be taken into account.

Our challenge in Diabetes Care

Continuous glucose monitoring (CGM) has significantly improved the management of diabetes for individuals on multiple daily injections of Insulin (MDI). However, to expand the benefits of CGM to a broader audience, such as fixed insulin users and those on oral diabetes medications, a strategic approach backed by scientific evidence is necessary. This internship aims to explore the opportunities for expanding the business of CGMs in the Netherlands by researching necessary steps and compiling relevant scientific evidence.

The aim of the internship is to understand the market potential and business opportunities of expanding CGM usage to fixed insulin users and patients on oral medications, and to determine the barriers and enablers to make this expansion feasible and successful.

Early detection and screening for heart failure at the GP

The use of NT-proBNP for the early detection of heart failure in the GP offices is only conducted minimally. Even though in asymptomatic diabetes patients, the prevalence of undetected heart failure is nearly 30%. There are currently more than 1 million diabetes type 2 patients in the Netherlands, who might benefit from repeated NT-proBNP measurements for the detection of heart failure.

Diagnosing these patients allows them to be treated, and there are reports that this reduces hospitalisations. Analyses from other countries reported that NT-proBNP in the early detection of heart failure was cost-effective. The aim of this internship is to understand the business potential, the barriers and enablers, and the cost-effectiveness of NT-proBNP measurements in the GP office. In order to achieve this, the internship will be interacting with KOLs, GPs, insurance companies and internal stakeholders.

Our challenge in bringing across the value of Dx in primary care

In the Dutch primary healthcare system, measuring blood-based biomarkers is not mainstay for most patients. Although nearly all GPs have access to measuring biomarkers in their patients, this is only partially reimbursed. Patients have a deductible of at least 385 euros. Furthermore, biomarker measurements are compared between multiple GPs, and when there are outliers in biomarker measurements, these GPs can be held accountable.

With this internship you will look into the reimbursement landscape of Dx in primary care, explore barriers and enablers to reimbursement, and the interest and responsibilities of the key stakeholders in the healthcare system. Especially in the light of IZA ( Integraal Zorg Akkoord ) and Passende Zorg , with the aim to move care closer to home and to prevent care later in the care path, and with all the innovations entering the market to enable this movement.

What you could do next

Do you want to learn more about these internships? Please contact our Talent Acquisition Partner, Matthijs van Heusden: 06 41607509 or matthijs.van_heusden@roche.com .

Are you open to exploring this internship opportunity further? Please apply via the apply now button and send us your motivation for the preferred internship topic.

Who we are

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Roche is an Equal Opportunity Employer.